(-)-demecolcine increases expression ISO RGD:732641 6480464 Demecolcine results in increased expression of OGA mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate decreases expression ISO RGD:732641 6480464 epigallocatechin gallate results in decreased expression of OGA mRNA CTD PMID:16084531 1,2-dichloroethane decreases expression ISO RGD:732642 6480464 ethylene dichloride results in decreased expression of MGEA5 mRNA CTD PMID:28960355 1,2-dimethylhydrazine affects expression ISO RGD:732642 6480464 1, 2-Dimethylhydrazine affects the expression of MGEA5 mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression ISO RGD:732642 6480464 Ethinyl Estradiol results in increased expression of OGA mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:732642 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of OGA mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression ISO RGD:732642 6480464 Ethinyl Estradiol affects the expression of OGA mRNA CTD PMID:17555576 17beta-estradiol decreases expression ISO RGD:732641 6480464 Estradiol results in decreased expression of OGA mRNA CTD PMID:19167446 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:732641 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:732642 6480464 Tetrachlorodibenzodioxin results in increased expression of OGA mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of OGA mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of OGA mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:732642 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of OGA mRNA, Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to OGA promoter] CTD PMID:17942748 , PMID:19654925 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of OGA mRNA CTD PMID:21346803 2-methylcholine affects expression ISO RGD:732641 6480464 beta-methylcholine affects the expression of OGA mRNA CTD PMID:21179406 3,3',5,5'-tetrabromobisphenol A decreases activity EXP 6480464 tetrabromobisphenol A results in decreased activity of OGA protein CTD PMID:31332466 3,4-methylenedioxymethamphetamine increases expression ISO RGD:732642 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of OGA mRNA CTD PMID:20188158 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of OGA protein CTD PMID:34915118 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:732641 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of OGA mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of OGA mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO RGD:732641 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of OGA mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO RGD:732641 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of OGA protein CTD PMID:34186270 4,4'-sulfonyldiphenol increases expression EXP 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of OGA mRNA CTD PMID:31332466 4,4'-sulfonyldiphenol decreases activity EXP 6480464 bis(4-hydroxyphenyl)sulfone results in decreased activity of OGA protein CTD PMID:31332466 aflatoxin B1 increases expression ISO RGD:732642 6480464 Aflatoxin B1 results in increased expression of OGA mRNA CTD PMID:19770486 all-trans-retinoic acid decreases expression ISO RGD:732641 6480464 Tretinoin results in decreased expression of OGA mRNA CTD PMID:15498508 all-trans-retinoic acid increases expression ISO RGD:732641 6480464 Tretinoin results in increased expression of OGA mRNA CTD PMID:23724009 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of OGA mRNA CTD PMID:16483693 aristolochic acid A decreases expression ISO RGD:732641 6480464 aristolochic acid I results in decreased expression of OGA mRNA CTD PMID:33212167 atrazine increases expression EXP 6480464 Atrazine results in increased expression of OGA mRNA CTD PMID:36841081 beauvericin increases expression ISO RGD:732641 6480464 beauvericin results in increased expression of OGA mRNA CTD PMID:29203277 benzo[a]pyrene multiple interactions ISO RGD:732642 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of OGA mRNA CTD PMID:27858113 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:732641 6480464 7 more ... CTD PMID:19150397 , PMID:20018196 benzo[a]pyrene diol epoxide I affects expression ISO RGD:732641 6480464 7 more ... CTD PMID:26238291 benzo[b]fluoranthene multiple interactions ISO RGD:732642 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of OGA mRNA CTD PMID:27858113 bisphenol A decreases expression ISO RGD:732641 6480464 bisphenol A results in decreased expression of OGA mRNA, bisphenol A results in decreased expression of OGA protein CTD PMID:22576693 , PMID:31675489 bisphenol A increases expression ISO RGD:732641 6480464 bisphenol A results in increased expression of OGA protein CTD PMID:34186270 bisphenol A multiple interactions ISO RGD:732642 6480464 bisphenol A inhibits the reaction [Cesium-137 results in increased activity of OGA protein] CTD PMID:29477810 bisphenol A multiple interactions EXP 6480464 bisphenol A results in increased expression of and results in decreased activity of OGA protein CTD PMID:31332466 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of OGA mRNA CTD PMID:30816183 , PMID:32528016 bisphenol A increases activity ISO RGD:732642 6480464 bisphenol A results in increased activity of OGA protein CTD PMID:29477810 bisphenol A increases methylation ISO RGD:732641 6480464 bisphenol A results in increased methylation of OGA gene CTD PMID:22576693 Bisphenol B increases expression EXP 6480464 bisphenol B results in increased expression of OGA mRNA CTD PMID:31332466 Bisphenol B multiple interactions EXP 6480464 bisphenol B results in increased expression of and results in decreased activity of OGA protein CTD PMID:31332466 bisphenol F multiple interactions ISO RGD:732641 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of OGA mRNA CTD PMID:28628672 bisphenol F decreases activity EXP 6480464 bisphenol F results in decreased activity of OGA protein CTD PMID:31332466 butyric acid increases expression ISO RGD:732641 6480464 Butyric Acid results in increased expression of OGA mRNA, Butyric Acid results in increased expression of OGA protein CTD PMID:27231347 cadmium atom multiple interactions ISO RGD:732641 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of OGA mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO RGD:732641 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of OGA mRNA CTD PMID:35301059 caffeine increases phosphorylation ISO RGD:732641 6480464 Caffeine results in increased phosphorylation of OGA protein CTD PMID:35688186 carbon nanotube decreases expression ISO RGD:732642 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:732641 6480464 CGP 52608 promotes the reaction [RORA protein binds to MGEA5 gene] CTD PMID:28238834 chloropicrin increases expression ISO RGD:732641 6480464 chloropicrin results in increased expression of OGA mRNA CTD PMID:26352163 chlorpyrifos decreases expression ISO RGD:732642 6480464 Chlorpyrifos results in decreased expression of OGA mRNA CTD PMID:37019170 choline multiple interactions ISO RGD:732642 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of OGA mRNA CTD PMID:20938992 chrysene multiple interactions ISO RGD:732642 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of OGA mRNA CTD PMID:27858113 ciguatoxin CTX1B affects expression ISO RGD:732642 6480464 Ciguatoxins affects the expression of OGA mRNA CTD PMID:18353800 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of OGA mRNA CTD PMID:24386269 colistin multiple interactions ISO RGD:732641 6480464 MRGPRX2 protein affects the reaction [Colistin results in increased secretion of OGA protein] CTD PMID:31132327 colistin increases secretion ISO RGD:732641 6480464 Colistin results in increased secretion of OGA protein CTD PMID:31132327 copper atom multiple interactions ISO RGD:732641 6480464 [NSC 689534 binds to Copper] which results in increased expression of OGA mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:732641 6480464 [NSC 689534 binds to Copper] which results in increased expression of OGA mRNA CTD PMID:20971185 coumestrol decreases expression ISO RGD:732641 6480464 Coumestrol results in decreased expression of OGA mRNA CTD PMID:19167446 crocidolite asbestos increases expression ISO RGD:732641 6480464 Asbestos, Crocidolite results in increased expression of OGA mRNA CTD PMID:25351596 dapagliflozin multiple interactions EXP 6480464 dapagliflozin inhibits the reaction [[Streptozocin co-treated with Fructose] results in increased expression of and results in increased secretion of OGA protein] CTD PMID:30551545 deoxynivalenol increases expression ISO RGD:732641 6480464 deoxynivalenol results in increased expression of OGA mRNA CTD PMID:31863870 dexamethasone multiple interactions ISO RGD:732641 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of OGA mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of OGA mRNA CTD PMID:28628672 dicrotophos decreases expression ISO RGD:732641 6480464 dicrotophos results in decreased expression of OGA mRNA CTD PMID:28302478 dorsomorphin multiple interactions ISO RGD:732641 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OGA mRNA CTD PMID:27188386 enzyme inhibitor decreases activity ISO RGD:732641 6480464 Enzyme Inhibitors results in decreased activity of OGA protein CTD PMID:23301498 enzyme inhibitor multiple interactions ISO RGD:732641 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of AAAS protein more ... CTD PMID:23301498 epoxiconazole decreases expression ISO RGD:732642 6480464 epoxiconazole results in decreased expression of OGA mRNA CTD PMID:35436446 ethanol affects splicing ISO RGD:732642 6480464 Ethanol affects the splicing of OGA mRNA CTD PMID:30319688 ethanol affects expression ISO RGD:732642 6480464 Ethanol affects the expression of OGA mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression ISO RGD:732641 6480464 Ethyl Methanesulfonate results in increased expression of OGA mRNA CTD PMID:23649840 ferric ammonium citrate multiple interactions ISO RGD:732642 6480464 ferric ammonium citrate inhibits the reaction [Ozone results in increased expression of OGA protein] CTD PMID:24862973 folic acid multiple interactions ISO RGD:732642 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of OGA mRNA CTD PMID:20938992 formaldehyde increases expression ISO RGD:732641 6480464 Formaldehyde results in increased expression of OGA mRNA CTD PMID:23649840 fructose multiple interactions EXP 6480464 [Streptozocin co-treated with Fructose] results in increased expression of and results in increased secretion of OGA protein more ... CTD PMID:30551545 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of OGA mRNA CTD PMID:22061828 , PMID:33387578 hydralazine multiple interactions ISO RGD:732641 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of OGA mRNA CTD PMID:17183730 hydrogen peroxide affects expression ISO RGD:732641 6480464 Hydrogen Peroxide affects the expression of OGA mRNA CTD PMID:21179406 indometacin multiple interactions ISO RGD:732641 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of OGA mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of OGA mRNA CTD PMID:28628672 isoprenaline increases expression ISO RGD:732642 6480464 Isoproterenol results in increased expression of OGA mRNA CTD PMID:20003209 ivermectin decreases expression ISO RGD:732641 6480464 Ivermectin results in decreased expression of OGA protein CTD PMID:32959892 L-methionine multiple interactions ISO RGD:732642 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of OGA mRNA CTD PMID:20938992 leflunomide increases expression ISO RGD:732641 6480464 Leflunomide results in increased expression of OGA mRNA CTD PMID:28988120 , PMID:29427785 metformin multiple interactions EXP 6480464 Metformin inhibits the reaction [[Streptozocin co-treated with Fructose] results in increased expression of and results in increased secretion of OGA protein] CTD PMID:30551545 methyl methanesulfonate increases expression ISO RGD:732641 6480464 Methyl Methanesulfonate results in increased expression of OGA mRNA CTD PMID:23649840 Methylazoxymethanol acetate increases expression EXP 6480464 Methylazoxymethanol Acetate results in increased expression of OGA mRNA CTD PMID:28349193 methylparaben increases expression ISO RGD:732641 6480464 methylparaben results in increased expression of OGA mRNA CTD PMID:31745603 N-acetyl-L-cysteine decreases expression ISO RGD:732641 6480464 Acetylcysteine results in decreased expression of OGA mRNA CTD PMID:16084531 nickel dichloride increases expression ISO RGD:732641 6480464 nickel chloride results in increased expression of OGA mRNA CTD PMID:17312168 ozone increases expression ISO RGD:732642 6480464 Ozone results in increased expression of OGA protein CTD PMID:24862973 ozone multiple interactions ISO RGD:732642 6480464 ferric ammonium citrate inhibits the reaction [Ozone results in increased expression of OGA protein] CTD PMID:24862973 paracetamol increases expression ISO RGD:732641 6480464 Acetaminophen results in increased expression of OGA mRNA CTD PMID:21420995 , PMID:22230336 paracetamol affects expression ISO RGD:732642 6480464 Acetaminophen affects the expression of OGA mRNA CTD PMID:17562736 paracetamol affects expression ISO RGD:732641 6480464 Acetaminophen affects the expression of OGA mRNA CTD PMID:25458485 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:732642 6480464 [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of MGEA5 mRNA CTD PMID:36331819 polymyxin B2 increases secretion ISO RGD:732641 6480464 Polymyxin B results in increased secretion of OGA protein CTD PMID:31132327 polymyxin B2 multiple interactions ISO RGD:732641 6480464 MRGPRX2 protein affects the reaction [Polymyxin B results in increased secretion of OGA protein] CTD PMID:31132327 quercitrin increases expression ISO RGD:732641 6480464 quercitrin results in increased expression of OGA mRNA CTD PMID:25193878 resveratrol multiple interactions ISO RGD:732641 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of OGA mRNA CTD PMID:23557933 rotenone decreases expression ISO RGD:732641 6480464 Rotenone results in decreased expression of OGA mRNA CTD PMID:29955902 , PMID:33512557 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of OGA protein CTD PMID:35544339 SB 431542 multiple interactions ISO RGD:732641 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OGA mRNA CTD PMID:27188386 silicon dioxide increases expression ISO RGD:732641 6480464 Silicon Dioxide analog results in increased expression of OGA mRNA CTD PMID:25895662 sodium arsenate increases expression ISO RGD:732642 6480464 sodium arsenate results in increased expression of OGA mRNA CTD PMID:21795629 sodium arsenate decreases expression ISO RGD:732642 6480464 sodium arsenate results in decreased expression of MGEA5 mRNA, sodium arsenate results in decreased expression of OGA mRNA CTD PMID:21795629 , PMID:30953684 sodium arsenite decreases expression ISO RGD:732641 6480464 sodium arsenite results in decreased expression of OGA mRNA CTD PMID:28595984 , PMID:34032870 sodium arsenite decreases expression ISO RGD:732642 6480464 sodium arsenite results in decreased expression of OGA protein CTD PMID:29044176 streptozocin multiple interactions EXP 6480464 [Streptozocin co-treated with Fructose] results in increased expression of and results in increased secretion of OGA protein more ... CTD PMID:30551545 streptozocin multiple interactions ISO RGD:732641 6480464 Streptozocin binds to and results in decreased activity of OGA protein CTD PMID:18721751 sulforaphane increases expression ISO RGD:732641 6480464 sulforaphane results in increased expression of OGA mRNA CTD PMID:31838189 tamibarotene decreases expression ISO RGD:732641 6480464 tamibarotene results in decreased expression of OGA mRNA CTD PMID:15498508 tamoxifen affects expression ISO RGD:732642 6480464 Tamoxifen affects the expression of OGA mRNA CTD PMID:17555576 Tetrachlorobisphenol A decreases activity EXP 6480464 tetrachlorodian results in decreased activity of OGA protein CTD PMID:31332466 tetraphene multiple interactions ISO RGD:732642 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of OGA mRNA CTD PMID:27858113 tetraphene decreases expression ISO RGD:732642 6480464 benz(a)anthracene results in decreased expression of OGA mRNA CTD PMID:26377693 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of OGA mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:732642 6480464 titanium dioxide results in increased expression of OGA protein CTD PMID:27760801 titanium dioxide decreases expression ISO RGD:732642 6480464 titanium dioxide results in decreased expression of OGA mRNA CTD PMID:27760801 Tributyltin oxide increases expression ISO RGD:732642 6480464 bis(tri-n-butyltin)oxide results in increased expression of OGA mRNA CTD PMID:25270620 trichostatin A affects expression ISO RGD:732641 6480464 trichostatin A affects the expression of OGA mRNA CTD PMID:28542535 troglitazone decreases expression ISO RGD:732642 6480464 Troglitazone results in decreased expression of OGA mRNA CTD PMID:28973697 tungsten decreases expression ISO RGD:732642 6480464 Tungsten results in decreased expression of MGEA5 mRNA CTD PMID:30912803 urethane decreases expression ISO RGD:732641 6480464 Urethane results in decreased expression of OGA mRNA CTD PMID:28818685 urethane increases expression ISO RGD:732641 6480464 Urethane results in increased expression of OGA mRNA CTD PMID:28818685 valproic acid multiple interactions ISO RGD:732641 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of OGA mRNA more ... CTD PMID:17183730 , PMID:27188386 valproic acid decreases expression ISO RGD:732642 6480464 Valproic Acid results in decreased expression of OGA mRNA CTD PMID:21427059 valproic acid decreases expression ISO RGD:732641 6480464 Valproic Acid results in decreased expression of OGA mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:732641 6480464 Valproic Acid affects the expression of OGA mRNA CTD PMID:25979313 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of OGA mRNA CTD PMID:18042343 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of OGA mRNA CTD PMID:23034163 vincristine increases expression ISO RGD:732641 6480464 Vincristine results in increased expression of OGA mRNA CTD PMID:23649840
